CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-26 | Stueland Katherine Chief Executive Officer | Sale | −1,750 | $94.59 | $166K | 48,314 |
| 2025-03-26 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −80,000 | 240,000 | ||
| 2025-03-17 | Stueland Katherine Chief Executive Officer | Sale | −10,559 | $96.71 | $1.0M | 14,865 |
| 2025-03-17 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −3,749 | $96.71 | $363K | 8,492 |
| 2025-03-16 | Stueland Katherine Chief Executive Officer | Option exercise | +18,750 | 25,424 | ||
| 2025-03-16 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −18,750 | 150,000 | ||
| 2025-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | −7,197 | 12,241 | ||
| 2025-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −7,197 | 57,575 | ||
| 2025-03-15 | Stueland Katherine Chief Executive Officer | Grant or award · Restricted Stock Unit | +47,684 | 47,684 | ||
| 2025-03-15 | Feeley Kevin CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Unit | +15,261 | 15,261 | ||
| 2025-03-13 | Stueland Katherine Chief Executive Officer | Sale | −1,078 | $89.44 | $96K | 6,674 |
| 2025-03-13 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −402 | $90.05 | $36K | 5,044 |
| 2025-03-10 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −922 | $94.72 | $87K | 5,446 |
| 2025-03-10 | Stueland Katherine Chief Executive Officer | Sale | −2,731 | $94.73 | $259K | 7,752 |
| 2025-03-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +2,462 | 6,368 | ||
| 2025-03-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −2,462 | 17,235 | ||
| 2025-03-09 | Stueland Katherine Chief Executive Officer | Option exercise | +6,546 | 10,483 | ||
| 2025-03-09 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −6,546 | 45,826 | ||
| 2025-03-03 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −261 | $103.94 | $27K | 3,906 |
| 2025-03-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +717 | 4,167 |
Page 21 of 23 · 450 trades